OxThera Investors
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
Headquarters:
Stockholm, Stockholms Lan, Sweden
Employee Number:
11-50
Technology:
Advanced BioTech R&D
Industry:
PharmTech
Investor Type:
Healthcare Company
Founded Date:
2005